Showing results (1-10 of 2,935) with videos related to
Sort By:
Pageof 294
Expert Opinion on Investigational Drugs|November 30, 2004
Novel therapies for the prevention of strokeChristopher J Boos, Gregory Y H LipExpert Review of Cardiovascular Therapy|August 4, 2005
Ximelagatran for stroke prevention in atrial fibrillationChristopher J Boos, Gregory Y H LipCurrent Pharmaceutical Design|May 30, 2006
Is hypertension an inflammatory process?Christopher J Boos, Gregory Y H LipAnnals of Medicine|October 16, 2007
The effects of exercise stress testing on soluble E-selectin, von Willebrand factor, and circulating endothelial cells as indices of endothelial damage/dysfunctionChristopher J Boos, Balu Balakrishnan, Gregory Y H LipThe American Journal of Cardiology|September 11, 2007
Endotoxemia, inflammation, and atrial fibrillationChristopher J Boos, Gregory Y H Lip, Bernd JilmaJournal of Thrombosis and Thrombolysis|June 19, 2007
The effects of coronary artery disease severity on time-dependent changes in platelet activation indices in stored whole bloodChristopher J Boos, Balu Balakrishnan, Gregory Y H LipVascular Health and Risk Management|June 23, 2007
Management of atrial fibrillationPuneet Kakar, Christopher J Boos, Gregory Y H LipBMJ Clinical Evidence|May 22, 2015
Atrial fibrillation (chronic)Deirdre A Lane, Christopher J Boos, Gregory Y H LipAnnals of Medicine|March 17, 2007
Assessment of platelet activation indices using the ADVIATM 120 amongst 'high-risk' patients with hypertensionChristopher J Boos, Gareth D Beevers, Gregory Y H LipJournal of the American College of Cardiology|October 19, 2006
Circulating endothelial cells in cardiovascular diseaseChristopher J Boos, Gregory Y H Lip, Andrew D BlannPageof 294